Show simple item record

dc.contributor.authorCaduff, Nicole
dc.contributor.authorMcHugh, Donal
dc.contributor.authorRieble, Lisa
dc.contributor.authorForconi, Catherine S.
dc.contributor.authorOng'echa, John M.
dc.contributor.authorOluoch, Peter O.
dc.contributor.authorRaykova, Ana
dc.contributor.authorMurer, Anita
dc.contributor.authorBöni, Michelle
dc.contributor.authorZuppiger, Lara
dc.contributor.authorSchulz, Thomas F.
dc.contributor.authorBlackbourn, David J.
dc.contributor.authorChijioke, Obinna
dc.contributor.authorMoormann, Ann M.
dc.contributor.authorMünz, Christian
dc.date.accessioned2022-01-08T14:53:01Z
dc.date.available2022-01-08T14:53:01Z
dc.date.issued2021-05-04
dc.identifier.citationCaduff , N , McHugh , D , Rieble , L , Forconi , C S , Ong'echa , J M , Oluoch , P O , Raykova , A , Murer , A , Böni , M , Zuppiger , L , Schulz , T F , Blackbourn , D J , Chijioke , O , Moormann , A M & Münz , C 2021 , ' KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection ' , Cell Reports , vol. 35 , no. 5 , 109056 . https://doi.org/10.1016/j.celrep.2021.109056en
dc.identifier.issn2211-1247
dc.identifier.otherPURE: 211300208
dc.identifier.otherPURE UUID: e07abcfa-b78f-4426-93b0-eeab416c69f9
dc.identifier.otherScopus: 85105035012
dc.identifier.otherPubMed: 33951431
dc.identifier.urihttps://hdl.handle.net/2164/17808
dc.descriptionFunding Information: This research was supported in part by Cancer Research Switzerland , Switzerland ( KFS-4091-02-2017 ); KFSP-PrecisionMS and HMZ ImmunoTargET of the University of Zurich , Switzerland; the Cancer Research Center Zurich , Switzerland; the Vontobel Foundation , Switzerland; the Baugarten Foundation , Switzerland; the Sobek Foundation , Germany; the Swiss Vaccine Research Institute , Switzerland; Roche , Switzerland; Novartis , Switzerland; and the Swiss National Science Foundation , Switzerland ( 310030B_182827 and CRSII5_180323 ). A.M.M. was funded by a National Institutes of Health , United States, grant ( R01 CA189806 ). N.C. was supported by a career advancement grant from the University of Zurich , Switzerland ( FK-18-026 ). D.M. and M.B. were supported by MD-PhD fellowships from the Swiss National Science Foundation , Switzerland, and the Swiss Academy of Medical Sciences , Switzerland ( 323530_145247 and 323630_19938 ).en
dc.format.extent20
dc.language.isoeng
dc.relation.ispartofCell Reportsen
dc.rightsThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en
dc.subjectCD56-negative NK cellsen
dc.subjectEBVen
dc.subjectEpstein-Barr virusen
dc.subjecthumanized mouse modelen
dc.subjectKaposi sarcoma-associated herpesvirusen
dc.subjectKSHVen
dc.subjectnatural killer cellsen
dc.subjectR Medicineen
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectOtheren
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleKSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infectionen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.celrep.2021.109056
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85105035012&partnerID=8YFLogxKen
dc.identifier.vol35en
dc.identifier.iss5en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record